CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Action Duchenne – Skip Duchenne Campaign
Clinical Research v4i3

Action Duchenne – Skip Duchenne Campaign

Nick Catlin at Charity Action Duchenne provides an overview of the research into a cure and effective medicines for Duchenne/Becker Muscular Dystrophy. The cha...
Continue Reading →
Planning and Performing Clinical Trials in Children and Adolescents
Clinical Research v4i3

Planning and Performing Clinical Trials in Children and Adolescents

Jaypreet Dhillon, Editorial Manager of Pharma Publications, Interviews Dr.  Hermann Schulz, Chief Executive Officer INTERLAB Central Lab Services – Worldwid...
Continue Reading →
Clinically-relevant in vitro and in vivo Oncology Models for Drug Discovery
Clinical Research v4i3

Clinically-relevant in vitro and in vivo Oncology Models for Drug Discovery

The success rate in predicting clinical efficacy of anti-cancer modalities using current xenograft models has been reported to be only 30-40%. Standard xenograft...
Continue Reading →
Centralised ECGs Help Ensure Cardiac Safety of Obesity Drugs
Clinical Research v4i3

Centralised ECGs Help Ensure Cardiac Safety of Obesity Drugs

Obesity rates have dramatically increased over the past 20 years, making it one of the most prevalent health problems in the world. Despite this, there are only ...
Continue Reading →
Allergy and Biopharmaceutical Therapy, Part 1: Background and Current Treatment Regimens
Clinical Research v4i3

Allergy and Biopharmaceutical Therapy, Part 1: Background and Current Treatment Regimens

A fairly good knowledge base concerning various steps in allergic reactions now exists, but despite this knowledge the prevalence of allergic diseases is still i...
Continue Reading →
Paediatric Clinical Trials in Europe and the US: Challenges and Solutions
Clinical Research v4i3

Paediatric Clinical Trials in Europe and the US: Challenges and Solutions

Pharmaceutical and biotech companies have a regulatory obligation to prepare plans for and conduct studies in paediatric patient populations in both EU countries...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026